Annual report pursuant to Section 13 and 15(d)

NON CONTROLLING INTEREST (Details)

v3.23.1
NON CONTROLLING INTEREST (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Net loss attributable to the non-controlling interest $ (7,419) $ (2,384)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss $ (18,782) $ (9,853)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%
Net loss attributable to the non-controlling interest $ (4,545) $ (2,384)
Joseph DeSanto MD [Member]    
Net loss $ (8,211)  
Average Non-controlling interest percentage of profit/losses 35.00%  
Net loss attributable to the non-controlling interest $ (2,874)